Tumors were eradicated in 30% of mice receiving cGAS LNPs injected into the tumor, in combination with immune checkpoint blockade.

By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers ...

China Medical University leads a multi-institution team reporting that MTAP deficiency suppresses cytosolic nucleic acid ...

By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers ...

An artificial intelligence model predicts how brain immune cells react to RNA and DNA nanoparticles, helping scientists design safer and more effective nucleic acid therapies faster.

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

Researchers found that lung and skin cancer patients who got COVID-19 vaccines reported significantly increased survival ...

Myeloid cells mediate interferon-driven resistance to immunotherapy inadvanced renal cell carcinomaPublication: Immunity - ...

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

Reviewers viewed the targeting of TFAM as innovative and the study's conclusions as potentially important (especially the effects on inflammation). However, the lack of evidence for a direct effect of ...

Scientists have developed a cancer vaccine that stopped three different types of aggressive tumors from growing in mice.